Sensei Biotherapeutics Inc. (SNSE) Statistics & Valuation Metrics - Stocknear

Sensei Biotherapeutics In...

NASDAQ: SNSE · Real-Time Price · USD
8.77
-0.25 (-2.77%)
At close: Sep 25, 2025, 3:57 PM
8.77
0.00%
After-hours: Sep 25, 2025, 06:06 PM EDT

Sensei Biotherapeutics Statistics

Share Statistics

Sensei Biotherapeutics has 1.26M shares outstanding. The number of shares has increased by 0.23% in one year.

1.26M
0.23%
0.23%
7.59%
828.3K
449
2.89%

Short Selling Information

The latest short interest is 10.29K, so 0.82% of the outstanding shares have been sold short.

10.29K
0.82%
1.21%
1

Valuation Ratios

The PE ratio is -8.16 and the forward PE ratio is -0.67. Sensei Biotherapeutics's PEG ratio is 4.98.

-8.16
-0.67
0
n/a
6.41
-9.92
4.98
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Sensei Biotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.7, with a Debt / Equity ratio of 0.1.

7.7
7.7
0.1
-0.13
-0.15
-362.38

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-2.15M
14
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -10.87% in the last 52 weeks. The beta is 0.27, so Sensei Biotherapeutics's price volatility has been higher than the market average.

0.27
-10.87%
8.14
8.38
55.56
15,519

Income Statement

n/a
-551K
-32.61M
-30.16M
-29.52M
-30.07M
-1.2
Full Income Statement

Balance Sheet

The company has 9.99M in cash and 3.85M in debt, giving a net cash position of 6.15M.

9.99M
3.85M
6.15M
-262.05M
31.78M
25.7M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.67M and capital expenditures -146K, giving a free cash flow of -24.82M.

-24.67M
-146K
-24.82M
-0.99
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SNSE is $55, which is 509.8% higher than the current price. The consensus rating is "Strong Buy".

$55
509.8%
Strong Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jun 17, 2025. It was a backward split with a ratio of 1:20.

Jun 17, 2025
backward
1:20

Scores

-12.61
1